| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,410,000 |
| Market
Cap: |
14.02(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$197.54 - $413.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 463 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
34 |
| Total Shares Sold |
1,742,072 |
2,404,472 |
3,519,952 |
3,608,378 |
| Total Sell Value |
$699,894,249 |
$883,563,199 |
$1,155,800,595 |
$1,175,475,107 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
39 |
65 |
82 |
89 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Troendle August J. |
President & CEO |
• • • |
2021-04-20 |
4 |
AS |
$182.44 |
$3,215,140 |
I/I |
(17,623) |
6,378,590 |
|
-2% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-04-19 |
4 |
AS |
$180.90 |
$1,532,404 |
D/D |
(8,471) |
6,396,213 |
|
-0% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-04-19 |
4 |
AS |
$180.90 |
$1,532,404 |
I/I |
(8,471) |
6,396,213 |
|
-0% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-04-16 |
4 |
AS |
$180.30 |
$3,160,298 |
I/I |
(17,528) |
6,404,684 |
|
0% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-04-16 |
4 |
AS |
$180.30 |
$3,160,298 |
D/D |
(17,528) |
6,404,684 |
|
0% |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2021-04-15 |
4 |
S |
$185.18 |
$703,684 |
D/D |
(3,800) |
13,854 |
|
3% |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2021-04-15 |
4 |
OE |
$28.32 |
$107,616 |
D/D |
3,800 |
17,654 |
|
- |
|
| Troendle August J. |
President & CEO |
• • • |
2021-04-15 |
4 |
AS |
$186.65 |
$5,836,546 |
I/I |
(31,270) |
6,422,212 |
|
-3% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-04-15 |
4 |
AS |
$186.65 |
$5,836,546 |
D/D |
(31,270) |
6,422,212 |
|
-3% |
|
| Geiger Jesse J |
CFO & COO, Lab Operations |
• – – |
2021-04-14 |
4 |
S |
$180.00 |
$540,000 |
D/D |
(3,000) |
6,382 |
|
-1% |
|
| Geiger Jesse J |
CFO & COO, Lab Operations |
• – – |
2021-04-14 |
4 |
OE |
$28.32 |
$84,960 |
D/D |
3,000 |
9,382 |
|
- |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2021-04-14 |
4 |
S |
$180.67 |
$216,804 |
D/D |
(1,200) |
13,854 |
|
-1% |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2021-04-14 |
4 |
OE |
$28.32 |
$33,984 |
D/D |
1,200 |
15,054 |
|
- |
|
| Troendle August J. |
President & CEO |
• • • |
2021-04-14 |
4 |
AS |
$180.48 |
$671,386 |
I/I |
(3,720) |
6,453,482 |
|
1% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-04-14 |
4 |
AS |
$180.48 |
$671,386 |
D/D |
(3,720) |
6,453,482 |
|
1% |
|
215 Records found
|
|
Page 9 of 9 |
|
|
6.16 (1.58%) 
